GI
GlenRock Israel
Private EquityActiveGlenRock Group leverages a unique combination of private equity, multidisciplinary in-house expertise, unmatched access to quality
23
Investments
4
Exits
—
AUM
17.4%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for GlenRock Israel.
Investment Thesis & Strategy
GlenRock Israel, as a private equity firm, invests in various stages across business development, life science, and management information systems, seeking companies with strong growth potential and the ability to leverage their in-house expertise.
Investment Activity
Deals per year over the last 1 years
4
2000Portfolio Companies
Selected investments from their portfolio of 23 companies
T
Teva Pharmaceutical Industries
Biotech · Growth, 2000
F
Frutarom
Food & Beverage · Growth, 2000
E
Elbit Systems
Other · Growth, 2000
T
Tower Semiconductor
Other · Growth, 2000
Frequently Asked Questions
GlenRock Israel focuses on Series B, Series C+ stage investments.